BiomX (PHGE) Free Cash Flow (2018 - 2026)
BiomX (PHGE) posted Free Cash Flow of -$5.4 million for Q1 2026, down 23.44% sequentially from -$4.4 million in Q4 2025, and up 37.86% YoY from -$3.9 million in Q1 2025.
BiomX (PHGE) Free Cash Flow (2018 - 2026) Analysis & Trends
BiomX has reported Free Cash Flow for 9 years, with the latest figure at -$5.4 million in Q1 2026.
- Quarterly Free Cash Flow rose 37.86% year-over-year to -$5.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$23.1 million (up 32.79% YoY) and the FY2025 annual result came in at -$26.4 million, up 28.69% from the prior year.
- Free Cash Flow eased to -$5.4 million in Q1 2026 per PHGE's latest filing, from -$4.4 million in the prior quarter.
- Over five years, Free Cash Flow peaked at -$4.1 million in Q2 2023 and troughed at -$11.2 million in Q2 2024.
- A 5-year average of -$6.7 million and a median of -$6.3 million in 2023 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2023 and 2024: Free Cash Flow soared 55.38% in 2023, then sank 175.55% in 2024.
- Over 5 years, Free Cash Flow stood at -$7.2 million in 2022, then rose by 13.21% to -$6.2 million in 2023, then decreased by 0.82% to -$6.3 million in 2024, then surged by 30.38% to -$4.4 million in 2025, then retreated by 23.44% to -$5.4 million in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$5.4 million, -$4.4 million, and -$7.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -563.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 437.80 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 292.04 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 433.84 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -95.09 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 477.44 Mn |
| 10 | BiomX | 351,774.34 | -816,225.66 | - | -5.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.41 Mn |
| Mar 31, 2026 | -5.41 Mn |
| Dec 31, 2025 | -4.39 Mn |
| Dec 31, 2025 | -4.39 Mn |
| Sep 30, 2025 | -7.18 Mn |
| Sep 30, 2025 | -7.18 Mn |
| Jun 30, 2025 | -6.11 Mn |
| Jun 30, 2025 | -6.11 Mn |
| Mar 31, 2025 | -8.71 Mn |
| Mar 31, 2025 | -8.71 Mn |
| Dec 31, 2024 | -6.30 Mn |
| Dec 31, 2024 | -6.30 Mn |
| Sep 30, 2024 | -8.11 Mn |
| Sep 30, 2024 | -8.11 Mn |
| Jun 30, 2024 | -11.24 Mn |
| Jun 30, 2024 | -11.24 Mn |
| Dec 31, 2023 | -6.25 Mn |
| Dec 31, 2023 | -6.25 Mn |
| Sep 30, 2023 | -5.95 Mn |
| Sep 30, 2023 | -5.95 Mn |